The CDC's FluSurge simulation shows that there will be a shortage of ventilators within the United States when the H5N1 flu virus mutates to airborne human-to-human transmission and the pandemic arrives. In the United States, it is estimated that nearly 85% of the 105,000 ventilators are in use at any time resulting, leaving in than 16,000 available to respond to a flu attack. However, for the suspected moderate to severe H5N1 Avian flu scenario, the need would be for over 65,000-742,500 ventilators conservatively costing $500 million to $6.2 billion to procure. Shared ventilation is a fundamentally unique approach which breaks the boundaries of current 1 ventilator to 1 patient mindset. The proposed project is to demonstrate and commercialize a next generation, largely disposable ventilator systems, which in its initial form, can use virtually any available ventilator and can provide ventilation for up to 6-8 patients without worries about cross contamination. In addition, each patient is provided individualized respiratory settings, including: oxygen concentration (Fi02), tidal volume and minute ventilation, and positive end expiratory pressure (PEEP). Furthermore, the system would significantly conserves oxygen, an equally scarce resource during pandemics, and cost ~1/3rd of any available alternative. Filing a 510k submission to the Food & Drug Administration is the final deliverable of this Phase I/II proposal.
Public Health Relevance: The Centers for Disease Control's (CDC) FluSurge simulation of likely pandemic scenarios highlights a nationwide shortage of more than 725,000 ventilators. In New York State alone, over 100,000 deaths are forecasted to be directly and indirectly caused by this lack of ventilators leading The New York State Department of Health to study the medical and ethical issues of ventilator rationing as the only solution. Medical Conservation Devices (MCD) provides an innovative approach to resolve two major shortages (ventilator availability and oxygen supply) anticipated during a pandemic scenario by making it possible for one ventilator to support multiple patients with individualized respiratory control without cross contamination.
Thesaurus Terms: Aerosols; Air; Aspiration, Respiratory; Automation; Avian Influenza; Bird Flu; Breathing; Cdc; Care, Health; Centers For Disease Control; Centers For Disease Control (U.S.); Centers For Disease Control And Prevention; Centers For Disease Control And Prevention (U.S.); Certification; Cessation Of Life; Characteristics; Death; Development; Devices; Engineering; Engineerings; Environment; Environmental Air Flow; Ethical Issues; Evaluation; Event; Fda; Fda Approved; Flu Virus; Food And Drug Administration; Food And Drug Administration (U.S.); Foundations; Fowl Pest; Fowl Plague; Funding; Gases; Goals; Government; Guidelines; H5n1; H5n1 Virus; Hosp; Health; Health Care Providers; Health Personnel; Healthcare; Healthcare Providers; Healthcare Systems; Healthcare Worker; Hospitals; Human; Human, General; Individual; Infection Control; Influenza A Virus, H5n1 Subtype; Influenza, Avian; Inhalation; Inhaling; Inspiration, Respiratory; International; Issues, Ethical; Laboratories; Left; Man (Taxonomy); Man, Modern; Marketing; Mechanical Ventilators; Mechanical Ventilation; Medical; Medical Device; Mutate; New York; Notification; O Element; O2 Element; Operation; Operative Procedures; Operative Surgical Procedures; Outcome; Output; Oxygen; Peep; Patient Admission; Patients; Performance; Phase; Phase Transition; Positive End-Expiratory Pressure; Positive-Pressure Respiration; Production; Research Resources; Resources; Respirators; Sbir; Sbirs (R43/44); Small Business Innovation Research; Small Business Innovation Research Grant; Solutions; Source; Surgical; Surgical Interventions; Surgical Procedure; System; System, Loinc Axis 4; Systems, Health Care; Technology; Testing; Tidal Volume; Time; Transmission; Usfda; United States; United States Centers For Disease Control; United States Centers For Disease Control And Prevention; United States Food And Drug Administration; Update; Validation; Ventilation; Ventilator; Ventilators, Mechanical; Ventilators, Pulmonary; Avian Flu; Base; Commercialization; Cost; Cost Effective; Design; Designing; Evaluation/Testing; Flu; Health Care Personnel; Health Care Worker; Health Provider; Healthcare Personnel; Influenza In Birds; Innovate; Innovation; Innovative; Inspiration; Mechanical Respiratory Assist; Medical Personnel; Meetings; Next Generation; Pandemic; Pandemic Disease; Positive Pressure Breathing; Prevent; Preventing; Product Development; Prototype; Public Health Relevance; Pulmonary Respirator; Respiratory; Respiratory Airway Volume; Simulation; Surgery; Technology Development; Transmission Process; Treatment Provider
